Abbott profit forecast gets a lift from St. Jude integration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
Abbott Labs (ABT) PT Raised to $56 at Deutsche Bank Following 2Q
July 21, 2017 8:37 AM EDTDeutsche Bank raised its price target on Abbott Labs (NYSE: ABT) to $56.00 (from $49.00) while maintaining a Buy rating following 2Q earnings report.... More
Abbott Labs (ABT) PT Raised to $57 at Barclays on 2Q Beat & FY17 EPS Raise; '2H Outlook Appears Bright'
July 21, 2017 8:32 AM EDTBarclays raised its price target on Abbott Labs (NYSE: ABT) to $57.00 (from $52.00) while maintaining a Overweight rating, following the company's second quarter earnings announcement.
Analyst Matthew Taylor notes the company delivered second quarter earnings per share and revenue results above the Street's... More
Abbott Labs (ABT) PT Raised to $62 at Argus on 2Q Beat & FY17 Raise; 'Positive View of Growth Prospects'
July 21, 2017 7:45 AM EDTArgus raised its price target on Abbott Labs (NYSE: ABT) to $62.00 (from $55.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.
Analyst David Toung notes the company delivered second quarter earnings per share above consensus projections driven by positive... More



